Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Mitochondrion. 2016 Aug 31;33:84–101. doi: 10.1016/j.mito.2016.08.017

Figure 4. BKCa channel transmembrane region interacts with Tom22.

Figure 4

(A) Scheme of wild type BKCa (1-1113) pore-forming α-subunit and different truncated proteins that were either expressed alone or co-expressed with Tom22. Numbers correspond to amino acid numbers in NCBI Accession No. U11058.2. S0-S6, transmembrane regions form the channel voltage sensor. Linker between S5-S6 forms the tetrameric channel pore region. Regulator of potassium conductance (RCK) 1 and 2 are Ca2+ sensors. (B) Dually labeled immunoblot for BKCa (top) and Tom22 (bottom) showing the ability of Tom22 to co-immunoprecipitate different BKCa channel regions (lanes 8-13, top). BKCa and Tom22 images were separated for clarity. Lanes 1-7 are controls expressing BKCa constructs or Tom22 alone. Squares and arrows mark the expected band sizes of each construct. Background signals (dashed squares, lanes 1-7, top) were much lower than the signals of the co-immunoprecipitated BKCa products (squares, lanes 8-13, top) and were subtracted to calculate Co-IP efficiency in (D). As control, the lower panel shows Tom22 successful immunoprecipitation. Tom22 was immunoprecipitated with anti-DDK mAb. Co-immunoprecipitated BKCa proteins were detected with anti-c-Myc pAb, and Tom22 was detected with anti-DDK mAb. (C) Control immunoblot of input lysates of cells expressing different BKCa regions (upper panel) and Tom22 (lower panel). BKCa constructs were detected with anti-c-Myc pAb and Tom22 was detected with anti-DDK mAb. Squares and arrows mark the expected band sizes. (D) Tom22 efficiency in pulling down different BKCa regions indicates that BKCa channel interacts with Tom22 mainly through the transmembrane domain (construct 1-343). Co-IP efficiency was calculated after subtracting background signals and calculating the ratio of the band intensities of co-immunoprecipitated BKCa constructs (i.e. B, top, lanes 8-13, squares) to corresponding immunoprecipitated Tom22 (i.e. B, lower panel, lanes 8-13), and normalized to BKCa construct intensities in the corresponding input lysates (i.e.. C, top, lanes 8-13). *, p<0.05 with respect to construct 1-343; #, p<0.05 with respect to the C-terminus (322-1113).